Viewing Study NCT06403254



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06403254
Status: RECRUITING
Last Update Posted: 2024-05-07
First Post: 2024-01-26

Brief Title: Evaluation of VSS Antibiotic Prophylaxis in Prosthetic Surgery MRSA
Sponsor: IRCCS Ospedale Galeazzi-SantAmbrogio
Organization: IRCCS Ospedale Galeazzi-SantAmbrogio

Study Overview

Official Title: Seeking Bacterial Prevalence for Targeted Pre-Surgical Antibiotic Prophylaxis in Prosthetic Surgery
Status: RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MRSA
Brief Summary: based on international guide lines antibiotic prophylaxis in Orthoaedic major surgery has to be done with a Cephalosporin 1st generation eg Cefazolin 1 g 30 before surgery

Since more than 10 years ago the investigators started evaluatinf infections in such a surgery well demosntrating a level below 1 and more important a responsability of MRSA considering Cephalosporin 1st generation useful but not determinat in such a surgery investigators consider the use of a Glycopepide Vancocyn 1 g in Very short The primary outcome is to evaluate the validity of such proposal performing a study of prevalence
Detailed Description: Patients enrolled in the study have to follow rhese steps

T0 Clinical evaluation and Cephalosporin VSS prophylaxis as usual T1 Surgery for TKA or THA T2 Post-operative -- control and if an infextion is supposed Coltural examination and ABG T3 Post-op orthopedic control at 6 months to evaluate any possible infection T4 Post-op clinical valuation at 12 months with the same goal

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None